CD11b(+)/Gr-1(+) immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1 beta-secreting cells
(2005) In Journal of Immunology 175(12). p.8200-8208- Abstract
- Tumor cells secreting IL-1 beta are invasive and metastatic, more than the parental line or control mock-transfected cells, and concomitantly induce in mice general immune suppression of T cell responses. Suppression strongly correlates with accumulation in the peripheral blood and spleen of CD11b(+)/Gr-1(+) immature myeloid cells and hematological alterations, such as splenomegaly, leukocytosis, and anemia. Resection of large tumors of IL-1 beta-secreting cells restored immune reactivity and hematological alterations within 7-10 days. Treatment of tumor-bearing mice with the physiological inhibitor of IL-1, the IL-1R antagonist, reduced tumor growth and attenuated the hematological alterations. Depletion of CD11b(+)/Gr-1(+) immature... (More)
- Tumor cells secreting IL-1 beta are invasive and metastatic, more than the parental line or control mock-transfected cells, and concomitantly induce in mice general immune suppression of T cell responses. Suppression strongly correlates with accumulation in the peripheral blood and spleen of CD11b(+)/Gr-1(+) immature myeloid cells and hematological alterations, such as splenomegaly, leukocytosis, and anemia. Resection of large tumors of IL-1 beta-secreting cells restored immune reactivity and hematological alterations within 7-10 days. Treatment of tumor-bearing mice with the physiological inhibitor of IL-1, the IL-1R antagonist, reduced tumor growth and attenuated the hematological alterations. Depletion of CD11b(+)/Gr-1(+) immature myeloid cells from splenocytes of tumor-bearing mice abrogated suppression. Despite tumor-mediated suppression, resection of large tumors of IL-1 beta-secreting cells, followed by a challenge with the wild-type parental cells, induced resistance in mice; protection was not observed in mice bearing tumors of mock-transfected fibrosarcoma cells. Altogether, we show in this study that tumor-derived IL-1 beta, in addition to its proinflammatory effects on tumor invasiveness, induces in the host hematological alterations and tumor-mediated suppression. Furthermore, the antitumor effectiveness of the IL-1R antagonist was also shown to encompass restoration of hematological alterations, in addition to its favorable effects on tumor invasiveness and angiogenesis that have previously been described by us. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/210741
- author
- Song, X P ; Krelin, Y ; Dvorkin, T ; Björkdahl, Olle LU ; Segal, S ; Dinarello, C A ; Voronov, E and Apte, R N
- organization
- publishing date
- 2005
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Immunology
- volume
- 175
- issue
- 12
- pages
- 8200 - 8208
- publisher
- American Association of Immunologists
- external identifiers
-
- pmid:16339559
- wos:000234030400050
- ISSN
- 1550-6606
- language
- English
- LU publication?
- yes
- id
- 77ef66f8-4c8d-47c2-aef1-bc31f84e5f56 (old id 210741)
- alternative location
- http://www.jimmunol.org/cgi/content/abstract/175/12/8200
- date added to LUP
- 2016-04-01 16:23:04
- date last changed
- 2018-11-21 20:41:01
@article{77ef66f8-4c8d-47c2-aef1-bc31f84e5f56,
abstract = {{Tumor cells secreting IL-1 beta are invasive and metastatic, more than the parental line or control mock-transfected cells, and concomitantly induce in mice general immune suppression of T cell responses. Suppression strongly correlates with accumulation in the peripheral blood and spleen of CD11b(+)/Gr-1(+) immature myeloid cells and hematological alterations, such as splenomegaly, leukocytosis, and anemia. Resection of large tumors of IL-1 beta-secreting cells restored immune reactivity and hematological alterations within 7-10 days. Treatment of tumor-bearing mice with the physiological inhibitor of IL-1, the IL-1R antagonist, reduced tumor growth and attenuated the hematological alterations. Depletion of CD11b(+)/Gr-1(+) immature myeloid cells from splenocytes of tumor-bearing mice abrogated suppression. Despite tumor-mediated suppression, resection of large tumors of IL-1 beta-secreting cells, followed by a challenge with the wild-type parental cells, induced resistance in mice; protection was not observed in mice bearing tumors of mock-transfected fibrosarcoma cells. Altogether, we show in this study that tumor-derived IL-1 beta, in addition to its proinflammatory effects on tumor invasiveness, induces in the host hematological alterations and tumor-mediated suppression. Furthermore, the antitumor effectiveness of the IL-1R antagonist was also shown to encompass restoration of hematological alterations, in addition to its favorable effects on tumor invasiveness and angiogenesis that have previously been described by us.}},
author = {{Song, X P and Krelin, Y and Dvorkin, T and Björkdahl, Olle and Segal, S and Dinarello, C A and Voronov, E and Apte, R N}},
issn = {{1550-6606}},
language = {{eng}},
number = {{12}},
pages = {{8200--8208}},
publisher = {{American Association of Immunologists}},
series = {{Journal of Immunology}},
title = {{CD11b(+)/Gr-1(+) immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1 beta-secreting cells}},
url = {{http://www.jimmunol.org/cgi/content/abstract/175/12/8200}},
volume = {{175}},
year = {{2005}},
}